Studying at the University of Verona
Here you can find information on the organisational aspects of the Programme, lecture timetables, learning activities and useful contact details for your time at the University, from enrolment to graduation.
Study Plan
This information is intended exclusively for future freshmen who will enroll for the 2026/2027 academic year.If you are already enrolled in this course of study, consult the information available on the course page:
Combined Bachelor's + Master's degree in Pharmacy - Enrollment until 2025/2026The Study Plan includes all modules, teaching and learning activities that each student will need to undertake during their time at the University.
Please select your Study Plan based on your enrollment year.
1° Year
| Modules | Credits | TAF | SSD |
|---|
2° Year It will be activated in the A.Y. 2027/2028
| Modules | Credits | TAF | SSD |
|---|
3° Year It will be activated in the A.Y. 2028/2029
| Modules | Credits | TAF | SSD |
|---|
4° Year It will be activated in the A.Y. 2029/2030
| Modules | Credits | TAF | SSD |
|---|
5° Year It will be activated in the A.Y. 2030/2031
| Modules | Credits | TAF | SSD |
|---|
| Modules | Credits | TAF | SSD |
|---|
| Modules | Credits | TAF | SSD |
|---|
| Modules | Credits | TAF | SSD |
|---|
| Modules | Credits | TAF | SSD |
|---|
| Modules | Credits | TAF | SSD |
|---|
| Modules | Credits | TAF | SSD |
|---|
Legend | Type of training activity (TTA)
TAF (Type of Educational Activity) All courses and activities are classified into different types of educational activities, indicated by a letter.
Radiochemistry and Radio Pharmacy (It will be activated in the A.Y. 2028/2029)
Teaching code
4S011739
Credits
9
Scientific Disciplinary Sector (SSD)
CHEM-03/A - Chimica generale e inorganica
Learning objectives
The first objective of the course is to provide basic knowledge on the chemistry of "hot" inorganic elements, coordination chemistry and its applications under physiological conditions. The student will be able to understand the properties - in terms of reactivity and radioactive decay processes - of a large number of radiopharmaceuticals clinically used in diagnostics, therapy or theranostics. The student will apply this knowledge at the molecular level in the study of new radiopharmaceuticals within a defined pathophysiological context.
At the end of the course the student will also be able to act in a multidisciplinary working context in close collaboration with the nuclear doctor, the health physicist, and other professional figures, starting from the selection of the therapy to the choice of the patient's path.
The course also aims to provide the student with an adequate level of culture to ensure that the preparation and dispensing of radiopharmaceuticals is performed according to procedures that ensure their safety and efficacy as medicines.